Philips spotlights latest AI-powered, software-defined MR smart systems at ECR 2022

2 years ago

Philips SmartSpeed MR software shot July 12, 2022  Philips SmartSpeed AI-based software receives FDA 510(k) clearance, delivering breakthrough high-speed, high-resolution…

Mainz Biomed Today to Provide Corporate Update for First Half of 2022

2 years ago

Company to Host Webcast Today - July 12th - at 4.00pm ETBERKELEY, Calif. and MAINZ, Germany, July 12, 2022 (GLOBE…

Sirona Biochem Corporate Update

2 years ago

VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides…

Vaccentis appoints Martin Munte as CEO and strengthens Board

2 years ago

Image of Vaccentis CEO Martin Munte, CEOMartin Munte has extensive leadership experience at Amgen, AstraZeneca and RocheStrengthening management after appointment…

LegoChem Biosciences and Glycotope Announce Research Collaboration and License Agreement for an Antibody for use as Antibody Drug Conjugate

2 years ago

Glycotope GlycotopeLegoChem Biosciences and Glycotope Announce Research Collaboration and License Agreement for an Antibody for use as Antibody Drug Conjugate…

Basilea announces Zevtera® (ceftobiprole) marketing authorization in Brazil

2 years ago

Basel/Allschwil, Switzerland, July 12, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today that its distribution partner…

Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management

2 years ago

NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025

2 years ago

Proceeds Support Advancement of Broad Pipeline of Novel Complement Product Candidates for Diseases of the Body, Brain and EyeBRISBANE, Calif.,…

Halberd Corporation Update, CEO Letter and 2022 Expectations

2 years ago

Q2 Accomplishments and a Look to the FutureJackson Center, Pennsylvania--(Newsfile Corp. - July 12, 2022) - Halberd Corporation (OTC Pink:…

Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - July 12, 2022) - Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") (CSE: EMH) (OTCQB:…